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Abstract 
This review demonstrates the detection of protease activity based on the energy transfer of 
quantum dots (QDs). By incorporation of varying protease substrates into designed QD 
probes both in fluorescence resonance energy transfer (FRET) and bioluminescence reso-
nance energy transfer (BRET) system, proteolytic activity led to changes in the energy transfer 
efficiency. Especially due to the superior properties of QDs, it can be served as an excellent 
probe for a multiplexed and high-throughput protease assay with high sensitivity. It is antic-
ipated that the QD-based FRET/BRET probes will have a great potential for dissecting the 
fundamental roles of proteases and designing potential protease inhibitors as therapeutic 
drugs in biology and nanomedicine. 
Key words: protease, quantum dot, energy transfer, BRET, FRET, multiplex, nanoparticle, lucifer-
ase, quencher 
1. Introduction 
The ability of enzymes to target the specific sub-
strate in complex milieu is essential for understanding 
the fidelity of most biological functions. Among en-
zymes, proteases, owing to their ability to regulate the 
physiological  functions  of  many  proteins  through 
initiating  irreversible  hydrolysis  at  the 
post-translational  level,  have  been  an  increasing  in-
terest in major human diseases such as cancer, AIDS, 
inflammation and neurodegenerative diseases [1, 2]. 
To this end, methods to assay proteases and their in-
hibitors  have  been  of  great  interest  in  diagnosis  of 
protease-relevant  diseases  and  development  of  po-
tential drugs [3-10]. Over the past decade, for probing 
the  abundance  of  proteases,  most  of  attempts  have 
relied on affinity-based methods such as immunoas-
say [11, 12], rather than the activity-based assay which 
can  provide  the  more  specificity  for  the  diagnostic 
value and drug discovery [13, 14]. A number of ap-
proaches to assay protease activity have been report-
ed traditionally based on liquid chromatography or 
gel  electrophoresis  [15,  16],  but  most  of  them  are 
time-consuming and laborious. 
With the recent advance of evaluating the prote-
olytic processes through genomic and proteomic ap-
proaches, short peptide substrates for many proteases 
have been identified, which could allow for a route to 
analyze and trace the activities of their matching pro-
teases in a rapid and facile manner [17, 18]. Therefore, 
assaying proteolytic activity can be easily designed by 
combining such peptide substrates with appropriate 
reporters, such as fluorescence and bioluminescence 
[19, 20]. The most useful system to assay the protease 
is  based  on  the  principle  of  fluorescence  resonance 
energy transfer (FRET) where two fluorophores (en-
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ergy donor and acceptor) are typically attached to the 
ends of the substrate with a distance of less than 10 
nm. FRET is a process in which energy is transferred 
nonradiatively from an exited state donor to a proxi-
mal ground state acceptor via resonant dipole-dipole 
interactions. While a peptide substrate is adjacent to 
both the donor and the acceptor, the activity of pro-
teases gives rise to the change in FRET efficiency. As a 
result of the cleavage of the peptide substrate by the 
protease, the energy transfer is disrupted and the ratio 
of  donor  to  acceptor  fluorescence  emission  changes 
when both chromophores are fluorescent, or the flu-
orescent  intensity  increases  when  the  acceptor  is  a 
quencher.  Although  popular  methods  to  adapt  this 
FRET-based principle for monitoring in vivo protease 
activity  has  been  made  by  using  genetically  engi-
neered fluorescence protein (typically CFP-YFP), the 
use  of  stable,  genetically  engineered  cell  lines  ex-
pressing the CFP-YFP substrate is much tedious and 
the real analysis of energy transfer is often hindered 
by  cross-talk  and  bleed-through  between  two  fluo-
rescent proteins with narrow Strokes shift. Thus, this 
system may not be suitable for monitoring the rapid 
turnover rate of many proteases. 
More recently, much attention has been given to 
the  development  of  highly  sensitive  protease  assay 
especially  by  merging  numerous  types  of  nano-
materials with improved detection properties. Among 
them, quantum dots (QDs) are the most attractable for 
biosensing  because  they  have  over-performed  pho-
tophysical properties than those of organic dyes and 
fluorescent  proteins.  First,  QDs  typically  have  very 
broad  absorption  spectra  with  very  large  molar  ex-
tinction coefficients of the order of 0.5–5×106 M−1 cm−1 
[21, 22] at wavelengths extending from the ultraviolet 
to the visible (Figure 1). This means that QDs are able 
to absorb 10–50 times more photons than organic dyes 
at the same excitation photon flux, providing a suffi-
cient brightness for the sensing system [23]. Second, 
size-tunable  QDs  are  characterized  by 
non-overlapping emission band profiles due to their 
narrow and symmetric emission bands (full width at 
half maximum of 25–40 nm) that can span the light 
spectrum  from  the  ultraviolet  to  the  infrared 
(400–1350 nm). This property enables the QDs to be 
useful for multiplexing assay in a single run [24-26]. 
For bioconjugation, QDs can be coated with organic 
molecules  and  macromolecules  to  provide  aqueous 
solubility. These coatings can be broadly classified as 
ligand-based  or  polymer-based,  and  neutral  or 
charged. Third, they possess an excellent photostabil-
ity (thousand-fold longer than conventional organic 
fluorophores) [27], quantum yield (the ratio of emit-
ted to absorbed photons) as high as 65−75% in most 
organometallic methods [28, 29] (but 20−25 % in the 
water-phase  synthesis),  and  long  fluorescence  life-
times (>10 ns) [30, 31]; thus, QD-based sensing and 
imaging have been successfully applied for continu-
ous  tracking  studies  over  a  long  period  of  time. 
Therefore, QDs can provide a potential solution for 
RET  system  because  the  conventional  organic  dyes 
cause  some  technical  problems  (e.g.  fast  photo-
bleaching  and  significant  emission  overlap  between 
donor  and  acceptor,  which  complicate  the  develop-
ment of robust and sensitive RET-based biosensors).  
 
 
Figure 1. Characters of quantum dot (QD). (A) Excitation (solid line) and emission spectra (dotted line) of CdSe quantum 
dots. (B) Size tuneability and emission color of five different QDs with the same long-wavelength UV lamp. (C) Structure of 
a QD nanocrystal: transmission electron microscope image of core shell QD at 200,000x magnification (left) and schematic 
of the overall structure (right). Figures were obtained from Invitrogen website (www.invitrogen.com). Theranostics 2012, 2(2) 
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In FRET system, QDs not only showed reliable 
switches from a quenched state (off) to a fluorescent 
state (on) [32, 33] without the crosstalk between the 
donor QD and the acceptor counterpart due to their 
large  Stokes  shift,  but  also  contibuted  to  multiple 
binding of an energy acceptor, leading to the increase 
in  overall  energy  transfer  efficiency  [34,  35].  Most 
significantly, the continuously tunable emissions that 
can  be  matched  to  any  desired  acceptor,  makes  it 
possible  to  use  many  fluorophores  for  multiplexed 
assay [36]. The quencher (orgarnic or metal [28, 37-40] 
substances)  or  emissive  fluorescent  molecules 
(fluorophores,  proteins,  or  other  QDs)  [41]  can  be 
promising  acceptors.  Although  QDs  are  primarily 
used as donors in FRET, they may also play a critical 
role as energy acceptors in bioluminescence resonance 
energy transfer (BRET), with a bioluminescent protein 
as the energy donor. BRET resembles FRET in many 
aspects except that it does not require external light 
source for the donor excitation. The broad excitation 
spectra and large Strokes shift of QDs allow them to 
be excited by nearly all the bioluminescent proteins in 
BRET constructs. Feasibility of QDs as the BRET ac-
ceptor  for  a  mutant  of  Renilla luciferase  (Luc8  with 
improved chemical stability and light efficiency) has 
been recently realized both in vitro and in vivo [42, 43]. 
This capability becomes even more attractive for im-
aging for protease activity which could not be easily 
detected by other organic dyes. 
Extensive reviews on QD-RET can be found in 
recent references [44-56], we will focus on the QD and 
energy  transfer-based  protease  detection  to  avoid 
redundancy in a myriad of applications of QDs. While 
much  emphasis  in  recent  years  has  been  placed  on 
“enzyme activity” in drug discovery, such QD-based 
RET  systems  offer  a  highly  sensitive  and  real-time 
monitoring strategy. Much attention to utilize the QD 
system  in  proteolytic  study  for  biotechnology  and 
nanomedicine applications is still on the way. A short 
overview regarding QD-FRET, QD-BRET, and multi-
plexed assay system is followed by some highlights of 
broad applications for the detection of protease activ-
ity.  Most  importantly,  promising  properties  of 
QD-based probes, alternative to organic dyes for flu-
orescence-based applications, is discussed in this re-
view. 
2. Analysis of protease activity using 
QD-FRET 
FRET is the most commonly utilized technique 
in these applications because of the high sensitivity, 
good reproducibility, and real-time monitoring capa-
bilities. Conventional methods to detect protease ac-
tivity  are  based  on  peptide-linked  organic  fluoro-
phores.  Examples  for  protease  activity  are  au-
to-quenched  probes  [57,  58],  dual  chromophore 
probes [59], and multiphoton FRET-based probes [60], 
as  depicted  in  Figure  2A.  However,  such  organic 
fluorophores  often  have  problems  such  as  photo-
bleaching, susceptibility to environment, difficulty in 
multiplexed analysis by specific paring between do-
nor and acceptor. As aforementioned, these problems 
in FRET assays can be overcome  when appropriate 
fluorophore or quencher is used in conjunction with 
quantum  dots  (QDs)[61,  62]  (Figure  2B). Since  QDs 
have broad absorption and narrow emission spectra 
as well as high photostability, they are favorable in 
long-term  monitoring  and  multiplexed  detection, 
where QDs are typically used as fluorescence donors 
while the fluorescent (or quenchable) acceptor is often 
an appropriately labeled peptide.  
In order to detect protease activity, energy ac-
ceptor groups (organic fluorophore or quencher [40, 
61-63])  were  first  bound  to  the  surface  of  a  QD 
through a peptide sequence. This close proximity al-
lows  for  quenching  of  the  QD  emission  via  FRET, 
while subsequent cleavage of the peptide sequence by 
protease activity leads to a recovery of the QD fluo-
rescence. A recent study by Shi et al. has shown a ra-
tiometric QD-FRET probe to measure protease activ-
ity in vivo, consisting of the donor QD and the accep-
tor rhodamine labeled peptide [62, 64]. Local excita-
tion  of  the  QDs  is  able  to  induce  efficient  energy 
transfer  into  the  adjacent  rhodamine  dye.  Approxi-
mately 48 numbers of a rhodamine dye labeled sub-
strate (RGDC) for collagenase were conjugated on a 
single  QD  through  a  sulfhydryl  group  of  cysteine 
residue. When the probes were first tested for trypsin 
(500 μg/mL for 15 min) in solution, they gave rise to 
60%  increase  in  the  photoluminescence  of  the  QDs 
and a corresponding decrease in the emission of the 
rhodamine molecules, based on FRET signal changes 
[64]. Similarly, upon the cleavage by collagenase, flu-
orescence from QD at 545 nm was recovered up to 
60% while that of rhodamine at 560 nm were dimin-
ished. Thus, ratiometric change in fluorescence emis-
sions of QD and rhodamine allowed for the real-time 
detection  and  quantification  of  collagenase  activity. 
The activity of collagenase, matrix metalloproteinases 
(MMPs)  was  monitored  in  normal  (HTB  125)  and 
cancerous breast cells (HTB 126) in which collagenase 
is negligible. This result clearly showed that QD-dye 
FRET sensors could be very useful to detect protease 
activity by measuring the ratiometric change. 
 Theranostics 2012, 2(2) 
 
http://www.thno.org 
130 
 
Figure 2. Schematic of FRET-based probe for the detection of protease activity. (A) conventional FRET (B) QD-based 
FRET. D and A indicate energy donor and energy acceptor, respectively. 
 
 
Mattoussi  group  has  reported  the  similar  ap-
proach to measure the activities of different proteases 
by  tuning  the  appropriate  peptide  substrate  [61]. 
Modular peptides were rationally designed to have 
four  different  parts;  i)  an  N-terminal  hexahistidine 
(His6)  domain  for  self-assembly  with  QD,  (ii)  a  he-
lix-linker  spacer  region,  (iii)  an  exposed  protease 
recognition/cleavage sequence, and (iv) a C-terminal 
site-specific  location  (cysteine  thiol)  for  dye  attach-
ment. In particular, the artificial residue alpha-amino 
isobutyric acid (Aib) and alanine were incorporated 
into the helix linker to provide rigidity, and an  or-
ganic fluorophore or a quencher was attached to the 
C-term  via  thiol  chemistry.  For  the  detection  of 
caspase-1 activity, dihydrolipoic acid (DHLA)-capped 
QD538 and the Cy3 was employed as the FRET pair, 
and  QD-FRET  probes  for  three  other  proteases 
(thrombin, collagenase and chymotrypsin) were also 
designed to have the quencher (QXL-520) instead of 
Cy3. They described that the relative FRET efficiency 
within  each  QD  nano-assembly  can  be  controlled 
through the number of peptides assembled per QD. 
Therefore, these assays provide quantitative data for 
protolytic activity by measuring enzymatic velocity, 
Michaelis–Menten  kinetic  parameters,  and  mecha-
nisms  of  enzymatic  inhibition.  Unlike  the  conven-
tional protease assay format in which substrate con-
centration  has  to  be  used  in  the  micromolar  range, 
they demonstrated that the developed format can be 
consistently used with lower substrate concentrations 
(200nM QD and peptide concentration of 0.2–1.0 μM) 
over a diverse selection of enzymes that manifest dif-
ferent specific activities. Moreover, it is likely that the 
substrates  incorporated  on  the  QD  complex  allow 
easy access to the desired protease and provide the 
high sensitivity and low background by being easily 
tuned. More recently, they utilized this system to de-
tect caspase 3 activity, a key downstream effector of 
apoptosis. Along with that, the presence of calcium 
ions with the acceptor CaRbCl can increase the FRET 
efficiency,  enabling  calcium-sensitizing  sensors  [65]. 
Also they have reported this QD-dye FRET system to 
serve as a papain or  proteinase K sensor, based on 
tunable coupler, 520 QD  and Cy3 [66]. In a similar 
way, Biswas et al. has showed that a genetically pro-
grammable protein module was designed to have a 
His6, a cleavage site labeled with a Alexa dye via cys-
teine residue, an elastin-like peptide (ELP) domain for 
purification,  and  a  flanking  TAT  peptide  [67].  This 
QD-dye FRET module was used for the detection of 
HIV-1 Pr activity in vitro and in cancer cells, which 
particularly  takes  responsibility  for  drug-resistance 
against  rapidly  mutating  viruses  such  as  HIV-1. 
Analysis of enzymatic inhibition was also performed 
in the presence of specific inhibitors. 
QD-FRET assay system to measure protease ac-Theranostics 2012, 2(2) 
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tivity has been applied to chip-based format by Kim et 
al [68].  While  the  photoluminescence  (PL)  of  donor 
streptavidin-QD525  immobilized  on  a  surface  was 
quenched due to the presence of an energy acceptor 
(peptide substrates modified with TAMRA and biotin 
at N- and C-terminus, respectively) in close proximi-
ty, the protease activity caused modulation in the ef-
ficiency of the energy transfer between the acceptor 
and donor, thus enabling the highly sensitive detec-
tion of MMP-7 activity. In contrast to a solution-based 
analysis, the chip-based format allowed more reliable 
analysis, with no aggregation of QDs. Plus, this for-
mat required a much smaller reaction volume. This 
method is likely to have a potential to screen the ac-
tivity  of  disease-associated  proteases  for  the  devel-
opment  of  therapeutics  and  diagnostics  in  a 
high-throughput manner. 
In addition to organic fluorophores, a fluorescent 
protein  was  easily  designed  as  an  energy  acceptor 
against  QD  donor.  Boeneman  et al [69]  has  demon-
strated that a red fluorescent protein (mCherry) ex-
pressing  the  caspase  3  cleavage  site  and  a  His6  se-
quence  were  self-assembled  to  the  surface  of 
CdSe–ZnS DHLA QDs via metal affinity coordination, 
leading to FRET quenching of the QD and sensitized 
emission  from  the  mCherry  acceptor.  Caspase-3  ac-
tivity caused the FRET efficiency to be reduced. Ow-
ing to the favorable spectral overlap (Förster distance 
R0=4.9 nm) between QD550 and mCherry, considera-
ble loss in QD PL was observed along with an increase 
in sensitized mCherry emission. A FRET efficiency of 
approximately 50% was measured when the number 
of  mCherry  per  a  single  QD  was  six.  Caspase 
3-induced changes in FRET efficiency were compara-
ble to those observed in fluorescent protein sensors. 
However, compared to two fluorescent proteins, some 
advantages  of  QD-fluorescent  protein  encompass 
5–10 times less substrate and ~3 orders of magnitude 
less enzyme in terms of quantity to be used. As a re-
sult, they were able to detect enzymatic activity for 
caspase 3 concentrations as low as 20 pM. This capa-
bility seems to be mainly due to multivalent effect of 
QDs. 
In order to construct QD-FRET probe, quenching 
groups  (organic  quenchers  or  metal  nanoparticles) 
[61-63,  70]  can  be  bound  to  the  surface  of  a  QD 
through  a  peptide  sequence.  Unlike  QD-dye  FRET 
system based on the ratiometry of dual emission, this 
close  proximity  causes  only  quenching  of  the  QD 
emission  via  the  resonance  energy  transfer,  while 
subsequent cleavage of the peptide sequence by the 
corresponding protease led to a recovery of the QD 
fluorescence.  The  quenching  ability  of  the  gold  na-
noparticle (AuNP) has been known to be much higher 
than that of organic quenchers as described elsewhere 
[38]. As such, the use of AuNPs as energy acceptors 
enables  the  energy  transfer  to  be  valid  even  in  the 
excess  distance  of  the  traditional  FRET.  One  of  the 
feasible  mechanisms  might  be  associated  with  the 
property of metal surface, termed nanosurface energy 
transfer (NSET); it was reported that the metal surface 
extended the effective energy transfer distance up to 
22 nm (an inversely fourth power distance depend-
ence),  resulting  in  a  high  energy  transfer  efficiency 
[71-75]. Although both NSET and FRET rely on dipo-
lar coupling, a longer distance dependence of NSET 
might be due to the cooperative effect of more acces-
sible acceptor dipoles yielding more dipolar interac-
tions.  NSET,  therefore  is  expected  to  have  diverse 
applications for measuring distances in excess of 10 
nm. Utilizing the NSET mechanism, the initial report 
of protease detection  with a QD-AuNP system was 
made  by  Chang  et  al  [63].  A  peptide  substrate, 
GGLGPAGGCG, was employed to measure the activ-
ity  of  collagenase.  When  the  surface  of  QDs  was 
capped with a layer of DHLA, mercaptosuccinic acid, 
or other carboxylic ligands, the N-terminal amines of 
the  peptides  were  easily  coupled  to  the  carboxylic 
acids on the QDs by EDC, and the cysteine was con-
jugated to the maleimide  functionalized gold  nano-
particles.  When  the  AuNP  level  was  six  per  QD,  a 
quenching efficiency of 71% was observed. The excess 
quenchers  on  the  QD  possibly  decrease  the  probe 
sensitivity to protease hydrolysis even if they cause 
the quenching efficiency to increase. By the release of 
the gold quencher in the presence of collagenase (0.2 
mg mL−1), QD fluorescence was recovered up to 51%, 
meaning that a number of enzyme molecules are not 
enough to be fully accessible between two large na-
noparticles. This observation that multivalent effect of 
QDs may induce a low detection sensitivity of enzyme 
is not consistent with the previous study [69] where 
the  increasing  number  of  fluorescent  proteins  per 
single  QD  increase  the  sensitivity.  This  may  be  at-
tributed  to  the  different  coupling  format.  The 
QD-FRET  between  QDs  and  fluorescent  acceptors 
depends on the ratio change of donor-to-acceptor in 
fluorescent  intensity  for  measuring  the  protease  ac-
tivity, while the QD-FRET using quenching acceptors 
relies on the single fluorescent intensity of the donor 
QD. Moreover, the recovery yield of QD-AuNP might 
be  more  complicated  than  that  of  QD-fluorescent 
protein  because  the  released  metal  quenchers  may 
significantly contribute to the QD emission in solution 
due to the random collision effect of metal surface, 
resulting  in  low  detection  sensitivity  of  tested  en-
zymes  (that  is,  low  recovery  efficiency  from  the 
quenching  state).  Therefore,  further  step  to  remove Theranostics 2012, 2(2) 
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the unbound acceptors (especially in metal acceptors) 
is desirable to increase the enzyme sensitivity as seen 
in the chip-based format [68]. 
3. Analysis of protease activity using 
QD-BRET 
Recent  studies  conducted  by  Rao  group  have 
demonstrated the feasibility of using QDs as the ac-
ceptor in a bioluminescence resonance energy transfer 
(BRET) system [42, 43]. In FRET, QDs are not able to 
function  as  effective  acceptors  [76]  because  a  direct 
excitation of donor fluorophores has to accompany by 
unavoidable  excitation  of  the  QD  with  a  broad  ab-
sorption. However, when QDs can serve as an energy 
acceptor  with a light-emitting protein, this problem 
can be overcome; since the bioluminescence energy of 
a luciferase-catalyzed reaction occurs only in its active 
site and cannot excite the acceptor QD, it can be suc-
cessfully transferred to the QDs to produce quantum 
dot  light  emission.  Upon  addition  of  the  luciferase 
substrate (coelenterazine) to QD-luciferase conjugate, 
a short blue light emission at 475 nm is transferred the 
QDs. Main advantage of QD-luciferase system is to 
eliminate the need for excitation light which causes 
inevitable background autofluorescence. In the case of 
QD-FRET that has been widely employed as activi-
ty-based probes, the  excited illumination can partly 
increase the background noise level especially in se-
rum sample, thus diminishing the value of acquired 
information  as  a  result  of  the  false-positive  signal. 
Moreover, a common luciferase protein serves as the 
BRET donor for several QDs with different colors be-
cause QDs have similar absorption spectra and absorb 
blue  light  efficiently.  Especially  in  contrast  to 
QD-FRET system where the FRET efficiency improves 
as the number of FRET acceptors per QD increases, 
the BRET ratio with varying numbers of luciferase on 
the surface of single QD were quite similar although 
the  intensity  of  both  luciferase  and  QD  emissions 
varied by approximately100-fold. This means that the 
QD-BRET  system  is  more  dependent  on  the  do-
nor-to-acceptor  distance  rather  than  varying  donor 
number,  thus  being  applied  to  detect  the  dis-
tance-dependent assay with high fidelity. In Figure 3, 
this QD-BRET based probe can be applied to the de-
tection of protease activity.  
 
 
Figure 3. Schematic of QD-BRET sensor to detect protease activity. QD and luciferase protein are closely linked together 
through a peptide substrate. In contrast to a quiescent state in the absence of protease (A), an active state (B) of this probe 
shows that protease cleavage removes the donor protein from QD and disrupts BRET, leading to a loss of biolumines-
cence-induced QD emission (red line).  
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Yao et al. has focused on the detection of the ac-
tivity of MMPs that is a promising cancer biomarker 
enzyme. Since the secretion level of MMPs in human 
serum is of very interest  as a promising prognostic 
marker [77, 78] due to the up-regulation of MMPs in 
almost all human cancerous cells or in malignant tis-
sues,  the  designed  probe  to  measure  MMP  activity 
and related inhibitory effect is valuable for discover-
ing  drug  candidates  for  anticancer  therapeutics 
[79-81]. For the construction of QD-BRET energy do-
nor,  a  bioluminescent  protein  fused  to  the  MMP-2 
substrate (GGPLGVR) and a hexahistidine tag at its C 
terminus was genetically expressed in E. coli. The bi-
oluminescent protein is a Renilla reniformis luciferase 
mutant dubbed Luc8, which has eight mutations and 
shows  higher  stability  and  improved  catalytic  effi-
ciency  than  the  wild-type  luciferase  [82].  Since  the 
simultaneous coordination is generated between car-
boxyl groups on the QD surface and the Luc8 His tag 
in the presence of Ni2+, a strong BRET signal was ob-
served  just  immediately  after  lucifer-
ase-GGPLGVRGGH6 is mixed with carboxyl QD655 
and Ni2+. Upon cleavage of the flanking peptide re-
gion by MMP-2, the His tag was released from the 
fusion Luc8 and the BRET signal decreased. In com-
parison to FRET-based QD sensors, BRET based QD 
biosensors have several attractive features. Most sig-
nificantly, the large spectral separation between the 
BRET donor and acceptor emissions makes it easy to 
detect  both  emissions.  In  this  case,  a  ratiometric 
measurement is far more accurate and reliable than 
that  of  QD-FRET  because  the  integrated  intensities 
from two separable spectra was favorable to reflect 
the  energy-transferred  efficiency  [43].  In  addition, 
considering that the BRET ratio for a concentration of 
MMP-2 of 2 ng  mL–1 (~30 pM) decreased by about 
10%, and by 15% for a concentration of MMP-2 of 5 ng 
mL–1 (~75 pM), the sensitivity is high probably due to 
a  low  background  emission.  However,  since  the 
overall sensitivity of protease assays is determined by 
several factors such as the peptidyl substrate, the par-
ticular  protease  of  interest,  the  conditions  (e.g.  pH, 
divalent  cations),  the  RET  efficiency,  the  acceptor 
quantum  yield  (for  ratiometric  sensing),  and  the 
background  signal  magnitude,  the  sensing  perfor-
mance  should  be  further  evaluated  by  comparing 
other  contributing  factors.  Main  drawback  of  this 
system is that it cannot be used in complex biological 
media such as serum because of widespread existence 
of chelate complex that might affect the enzyme sen-
sitivity as well as the electrostatic interaction of de-
signed nanosensor. The later issue (electrostatic inhi-
bition  in  serum)  can  be  overcome  with  site-specific 
conjugation.  Recently,  a  modified  QD-BRET  na-
nosensor with a stable covalent linkage has been de-
veloped by Xia et al., enabling the detection of prote-
ase  activity  in  mouse  sera  and  tumor  lysates  [83]. 
Once the QD-luciferase complex is premade with high 
affinity, the protease activity can be detected by dis-
sociation  of  the  linkage.  To  accomplish  the 
site-specific  conjugation,  the  carboxylated  QDs  had 
been  functionalized  with  adipic  dihydrazide  and 
subsequently  treated  with  the  luciferase–protease 
substrate recombinant protein with an additional in-
tein segment. Since hydrazides are excellent nucleo-
philes to attack the thioester intermediate of inteins 
that are natural protein ligation mediators. The reac-
tion  proceeded  rapidly  when  the  two  components 
were mixed together, and resulted in cleavage of the 
intein and ligation of the C terminus of the recombi-
nant protein to the QDs. 
Notwithstanding the crucial role of proteases in 
cellular function, the prognostic attempts have much 
been interrupted in serum level mainly because many 
interferences  for  activity-based  detection  exist.  By 
employing this strategy, a high level of sensitivity can 
be attained in a concentration range that would enable 
protease activity to be detected in complex biological 
media.  Most  significantly,  this  approach  by  using 
QD-BRET can provide a new family of activity-based 
assays  for  enzymes  and  their  inhibition  in  a 
high-throughput manner. 
4. Multiplexed analysis of protease activity 
Highly rapid and sensitive detection in a multi-
plexed  manner  has  been  of  great  interest  to  study 
clinical diagnostics, drug screening, and bio-imaging 
applications. The ability to identify multiple analytes 
in a single assay format has many advantages  over 
single-target systems; high-throughput screening, low 
consumption of reagents and samples, and decrease 
in errors between inter-sampling. Although many of 
powerful analytical methods are now available, fluo-
rescent  probes  have  long  been  used  to  characterize 
molecular  interactions  for  the  multiplexed  purpose, 
due  to  their  chemical  stability  and  sensitivity  [84]. 
However, the narrow absorption and large cross-talk 
of  organic  dyes  and  fluorescent  proteins  is  a  major 
hurdle for simultaneous detection of multiple signals, 
because of the requirement of an elaborate excitation 
and  the  complicated  analysis  of  collected  data. 
Moreover,  low  resistance  of  fluorescent  probes  to 
chemical and photodegradation can significantly limit 
their use in multiplexed monitoring. Since QD nano-
crystals can be simultaneously excited at a single ex-
citation wavelength, multicolored QDs make it possi-
ble to achieve simultaneous monitoring of biomole-
cules with high level of sensitivity and excellent pho-Theranostics 2012, 2(2) 
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tostability. 
A multiplexed system to detect the activity and 
inhibitory effects of several proteases (MMPs, throm-
bin, and caspase-3) has been proposed by Kim et al, 
which is utilized by the principle of energy transfer 
between  the  AuNP  and  respective  QDs  on  a  glass 
slide [40]. For construction of nanoprobes, The AuNP 
acceptors  conjugated  with  a  peptide  substrate  in-
cluding  cysteine  and  biotin  were  associated  with 
streptavidin  (SA)-conjugated  QDs  (SA-QDs,  energy 
donor) deposited on a glass slide, thus quenching the 
PL of the QD by the energy transfer. Upon addition of 
a  protease  to  cleave  the  peptide  substrate  on  the 
AuNP–QD conjugates, there was a significant regen-
eration  of  the  photoluminescence  emission  of  the 
QDs. Protease inhibitors also prevented any recovery 
of  the  photoluminescence  of  QDs  by  inhibiting  the 
protease  activity.  When  three  types  of  SA-QD 
(SA-QD525,  SAQD605,  and  SA-QD655)  were  inde-
pendently complexed with the AuNPs with different 
peptide substrates, a specific reaction of the protease 
induced  a  strong  photoluminescence  intensity  from 
each spot, at a specified wavelength (Figure 4A and 
4B). Marginal cross-reactional images of the protease 
against other peptide substrates were observed, thus 
confirming  the  multiplexed  capability  of  this  assay 
system. Since the AuNPs can be employed as a com-
mon energy acceptor, a variety of QDs with different 
colors could be used as the energy donor (Figure 4C), 
thus  enabling  a  multiplexed  assay.  Moreover,  high 
quenching efficiency of AuNPs allows application of 
the assay system to an extended separation distance 
between  a  donor  and  an  acceptor.  This  developed 
system also overcome some drawbacks resulting from 
a solution-based format, including the aggregation of 
nanoparticles  and  the  fluctuation  in  photolumines-
cence, and the consumption of large amounts of rea-
gents. 
 
 
 
Figure 4. Development of multiplexed system to detect protease activity with QDs. (A) Multiplexed assay of proteases by 
using QDs with different colors. SA-QD525, SA-QD605, and SA-QD655 were used (from left to right). Biotinylated peptide 
substrates for MMP-7, caspase-3, and thrombin were conjugated to the AuNPs, and then the resulting Pep-AuNPs were 
associated  with  SA-QD525,  SA-QD605,  and  SA-QD655,  respectively.  (a)  SA-QDs  only.  (b)  SA-QDs  +  respective 
Pep-AuNPs. (c) SA-QDs + Pep-AuNPs + MMP-7. (d) SA-QDs + Pep-AuNPs + caspase-3, (e) SA-QDs + Pep-AuNPs + 
thrombin. (f) QDs + Pep-AuNPs + mixture of the respective protease and its inhibitor. (B) High-resolution TEM images of 
QD-PepMMP7-AuNP assembly (left) before and (right) after incubation with MMP-7. The released AuNPs in enzyme-treated 
samples  were  removed  by  filtration.  (C)  Changes  in  the  PL  intensities  of  QDs  having  different  colors  (SA-QD525, 
SA-QD605, and SA-QD655) in the presences of biotinylated PepTHR-AuNPs in solution. The molar ratios of Pep-AuNPs to 
respective QDs were equally maintained at 50. Adapted with permission from [40]. Theranostics 2012, 2(2) 
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This  multiplexed  assay  using  a  QD-FRET  na-
nosensor has also been applied to different types of 
enzymes other than proteases. Suzuki  et al [84]. de-
signed QD-based nanoprobes on a FRET with QD as 
donor and an appended fluorophore as acceptor in 
order to detect multiple cellular signaling events, in-
cluding  the  activities  of  protease  (trypsin),  deoxyri-
bonuclease, and DNA polymerase, as well as changes 
in  the  pH.  Notably,  this  mixture  of  modified  QDs 
showed distinct changes in emission peaks before and 
after enzyme treatment by simultaneous-wavelength 
excitation in the same tube. 
Using  a  QD-BRET  nanosensor  which  provides 
great sensitivity due to its extremely low background, 
the  simultaneous  detection  of  MMP-2,  MMP-7,  and 
urokinase-type plasminogen activator (uPA) has been 
demonstrated  [83]  (Figure  5A).  Hydrazide  and  in-
tein-mediated conjugation makes the donor (lucifer-
ase) and acceptor (QD) to be assembled (Figure 5B), 
and the conjugated nanosensors were capable of de-
tecting  these  proteases  in  complex  biological  media 
with a sensitivity down to ~1 ng mL−1. In addition, 
they could also detect multiple proteases present in 
one  sample  (Figure  5C).  The  most  significant  point 
here is that the BRET ratio (i.e. the ratio of donor and 
acceptor emissions) between the QD and the lucifer-
ase was modulated only by the degree of the protease 
activity, thereby making it more reliable and sensitive 
in comparison with other assays. As mentioned earli-
er, elimination of physical light excitation resulted in 
high sensitivity of this QD-BRET system and makes it 
work  in  complex  biological  media  including  serum 
and tumor samples in a multiplexed way. 
 
 
Figure 5. Development of QD-BRET nanosensor to detect protease activity. (A) Schematic of the nanosensor comprising 
of a QD and luciferase proteins (Luc8) that are linked to the QD through an MMP peptide substrate and (B) intein-mediated 
site-specific conjugation of Luc8 fusion proteins to QDs. (C) Simultaneous detection of MMP-2 and uPA: A mixture of 
QD655-MMP-2-Luc8 (0.15 μM) and QD705-uPA-Luc8 (0.2 μM) were incubated with MMP-2 (1 μg/mL, red); uPA (10 μg/mL, 
black); MMP-2 (1 μg/mL) + uPA (10 μg/mL) (green); or no enzyme (blue) at room temperature for 1 h in 20 mM Tris buffer 
(pH 7.5). Adapted with permission from [83].  
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5. Conclusion 
In this review we demonstrate that there have 
been several technological advances that are likely to 
make  important  contributions  to  sensing  protease 
activity. Improved analysis of protease activity is now 
paving  the  way  of  understanding  the  physiological 
roles  of  many  proteases  in  complex  living  system. 
Also it is noteworthy that probing the protease activ-
ity  is  implicated  in  early  detection  of  both  primary 
tumors and some diseases that remains a major chal-
lenge. Hence, newly developed sensing and imaging 
system using QDs will be tremendously applied to the 
areas that require the rapid analysis and high sensi-
tivity. However, some limitations regarding specific-
ity and imaging resolution in vivo still remain formi-
dable. For example, temporal and spatial localization 
of protease activity with its specific substrate should 
be required in future studies to dissect the roles of 
many proteases. It is anticipated that the integration 
of biological information with improved nanosensors 
and  toolkits  will  allow  us  to  track  protease-specific 
activity over the long period. Moreover, by combining 
the QD-RET with protease-modulated sensors, ther-
apeutic approaches (e.g. siRNA delivery and photo-
dynamic therapy) will have a great potential in bio-
medicine and nanomedicine. 
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